3 April 2020

The 5th European Conference on Tobacco Control is postponed!


12-14 October 2020 - Paris, France


Due to growing concerns over the coronavirus (COVID-19), and with the well-being of attendees, partners and staff as the number one priority, the European Network for Smoking and Tobacco Prevention has decided to reschedule its annual conference. We are aware that the rapidly evolving situation will impact seriously on upcoming events and are hopeful that the global situation will be more favorable later this year. 


For this reason, we fully intend to host the 5th European Conference on Tobacco Control on 12-14 October 2020, but we will be monitoring the situation very closely and keep you updated. Following this change, the abstracts deadline for oral and poster presentations and symposia proposals will be extended. Therefore, we will be working with our partners to finalise the details and will share more information about the programme in the near future.

The final deadline for submissions of abstracts/symposia proposals is 
31 July 2020.

Abstract and symposia submissions remain open
New topic introduced!

Furthermore, a new topic has been introduced to the conference programme: Tobacco / Smoking/ Vaping & COVID-19.

We are encouraging submissions of abstracts and symposia proposals to the conference programme as the share of best practices, research and project results among the members of ENSP remains our key activity. 

Conference Registrations

Don't forget to register for the 5th European Conference on Tobacco Control and start planning your trip to Paris. Go to the ENSP ECTC website and find out more about the location, or stay up to date with the programme and other news.

Special news
COVID-19 and tobacco

Research and innovation:
The European Commission selects 18th project to develop rapid diagnostics

The Commission has decided to fund another project as part of its emergency call for urgently needed research and innovation into the coronavirus. This brings the number of supported projects up to 18 from the 17 originally announced, with a total budget of €48,5 million from Horizon 2020, the EU research and innovation programme.

These projects enable 140 research teams from across Europe working together to address the coronavirus pandemic. The newly selected project, called HG nCoV19 test and coordinated by an Irish company, will develop and validate a rapid molecular diagnostic test for the novel coronavirus.
Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said:  “Front-line health workers need to diagnose coronavirus more quickly and more accurately. This reduces the risk of further spread of the virus. I am happy that we can add another project to the EU-funded effort to develop rapid diagnostics.”
The 18 selected projects are swiftly starting to work on developing rapid diagnostics, treatments and vaccines as well as understanding the behaviour of the epidemic through epidemiology and modelling. Over the past weeks, the EU has also mobilised public and private funding of up to €90 million through the Innovative Medicines Initiative, and has offered up to €80 million of financial support to the innovative company CureVac to scale up development and production of a vaccine against the coronavirus.

The Commission's concrete support to 
urgently needed research and innovation is part of the common European response to the outbreak of the coronavirus. Several additional EU-funded research projects and initiatives are working on countering the spread of the disease and enhancing preparedness for other outbreaks.

Why coronavirus is deadlier among men than women
The smoking hypothesis


The coronavirus epidemic has spread not only deaths and bereavements, but also fear and anxiety all over the world. Although men and women were infected in nearly equal numbers, the researchers found that the mortality rate among men was double that of women: 2.8 vs 1.7. 

The President of Società Italiana di Tabaccologia,Vincenzo Zagà together with Silvano Gallus from Istituto di Ricerche Farmacologiche Mario Negri, Giuseppe Gorini from ISPRO Firenze and M. Sofia Cattaruzza from Università La Sapienza, Roma published an article explaining the smoking hypothesis in the context of coronavirus.

Read the full article (Italian)...

WHO guidelines:
how to maintain essential health services during COVID-19 pandemic

The COVID-19 pandemic is straining health systems worldwide. The rapidly increasing demand on health facilities and health care workers threatens to leave some health systems overstretched and unable to operate effectively.

To help countries navigate through these challenges, the World Health Organization (WHO) has updated operational planning guidelines in balancing the demands of responding directly to COVID-19 while maintaining essential health service delivery, and mitigating the risk of system collapse. This includes a set of targeted immediate actions that countries should consider at national, regional, and local level to reorganize and maintain access to high-quality essential health services for all.

Download the full document...
Moreover, the WHO FCTC Secretariat stresses the fact that smoking can increase your chance of getting COVID-19, as the act of smoking means that fingers (and possibly contaminated cigarettes) are in contact with lips which increases the possibility of transmission of virus from hand to mouth. Smokers may also already have lung disease or reduced lung capacity which would greatly increase risk of serious illness.


COVID-19 and Tobacco Industry Interference


On March 24, the Global Center for Good Governance in Tobacco Control published and article presenting the Tobaco Industry interference in the context of the COVID-19 epidemic, offering a series of reccomendations regarding smoking.

While the COVID-19 crisis presents an opportunity to encourage the world’s smokers to quit smoking outright, including quitting cold turkey, the tobacco industry is taking the opportunity to counter this by camouflaging the links between tobacco and COVID-19; and promoting vaping products or heated tobacco, even when there is no evidence that these products are safe in the context of transmitting or acquiring COVID-19.

While governments can seize the opportunity to save more lives than COVID-19 can take, the tobacco industry is poised to undermine governments’ credibility and ability to do so by “partnering with” or “donating to” them in the guise of so-called “corporate social responsibility,” and shifting public attention towards the use of vaping products and heated tobacco.


Action on Smoking and Health (ASH) campaign: 


On 18 March 2020, the ASH Health Secretary declared that  “It is abundantly clear that smoking makes the impact of a coronavirus worse”. As the Government again highlights the risks to smokers from COVID-19, Action on Smoking and Health (ASH) is joining health professionals in calling on smokers to #QuitforCovid. 

Evidence has shown both for electonic cigarettes and for secondhand smoke that vapers and people exposed to secondhand smoke face a higher, additional risk from coronavirus. Experts warn that smokers could be at greater risk of developing lung illness from coronavirus. The public health community is therefore encouraging smokers to quit, even in isolation. Quitting smoking remains the single most effective thing people can do to improve their and their family’s health both now and in the future.


Campaign for Tobacco Free Kids:

Building a Network of Tobacco Control Champions


Campaign for Tobacco Free Kids launches a program that aims at teaching trainees to strategically leverage influencer relationships to support their advocacy campaigns, in order to building a network of digital advocates.


A key means of driving engagement on social media channels is to develop relationships with committed advocated who are able to communicate with key audiences online. 


This program is designed for organizations that have seen positive results using social media, but are looking to expand their influence in new ways by solidifying influencer relationships with potential Tobacco Control Champions.  

Organizations that have the following characteristics are encouraged to apply to this program:

  • Have an active policy campaign in the next 6-8 months.  
  • Have been through our “Fundamentals of Digital Advocacy” training or have equivalent experience.  
  • Have active social media channels that you are managing.

The application period for this course has been extended and is now open until April 8. 
Now also indexed in PubMed Central. Learn more...
New published articles
Perceived social benefits versus perceived harms of smoking among Indonesian boys aged 12–16 years: A secondary analysis of Global Youth Tobacco Survey 2014
Nurul Kodriati, Elli Nur Hayati, Ailiana Santosa, Lisa Pursell

Innovative call emerging from a qualitative study for workplace designated stop-smoking area
Marie Chan Sun, Lovena Rathoa

Associations between Appalachian youth tobacco consumption and communication channel use
Delvon T. Mattingly, Jack Pfeiffer, Lindsay K. Tompkins, Jayesh Rai, Clara G. Sears, Kandi L. Walker, Joy L. Hart

Relationship between population characteristics, e-cigarette and tobacco-related perceptions, and likelihood of ever using e-cigarettes
Jack A. Pfeiffer, Lindsay K. Tompkins, Joy L. Hart, Anshula Kesh, Allison Groom, Thanh-Huyen T. Vu, Jennie Z. Ma, Robyn Landry, Thomas J. Payne, Aida L. Giachello, Rose Marie Robertson, Kandi L. Walker

Exposure to the advertisement of toombak at the point-of-sale among adolescents in Khartoum State, Sudan: A crosssectional study
Hatim M. Almahdi, Raouf W. Ali, Elwalid F. Nasir

Predictors of tobacco smoking among acutely ill patients in a Moscow hospital: A cross-sectional study
Aleksey Nadezhdin, Benedicte Joergenrud, Elena Tetenova, Evgeny Bryun, Evgenya Koshkina, Alexei Petukhov, Alexey Kolgashkin, Saranda Kabashi, Stig Tore Bogstrand

The package as a weapon of influence: Changes to cigarette packaging design as a function of regulatory changes in Canada
Wade S. Wade, Katherine White

Initial use of tobacco or marijuana and later use profiles in young adults
Amy J. Park, Milkie Vu, Regine Haardörfer, Michael Windle, Carla J. Berg

Effect of smokeless tobacco use on salivary glutathione levels among chronic periodontitis patients before and after nonsurgical periodontal therapy
Arati C. Koregol, Nagaraj B. Kalburgi, Pushpa Pattanashetty, Shivaraj Warad, Nandini S. Shirigeri, Vani C. Hunasikatti
Do you have an event coming up or news to celebrate? 
Would you like to share your best practices or inform about local initiatives?

Share your work and promote you activities among 2.000+ colleagues in Europe and around the globe via 
The Network - ENSP monthly newsletter
vaping360.com/iqos-philip-morris//e-cigarettes/ (Vaping360)
View this email in your browser
You are receiving this email because of your relationship with ENSP. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent to charis.girvalaki@gmail.com by cornel.radu@ensp.org
Chaussée d'Ixelles 144 Ixelles Brussels Belgium

Unsubscribe from all mailings Unsubscribe | Manage Subscription | |

This is a Test Email only.
This message was sent for the sole purpose of testing a draft message.